Association for Cancer Immunotherapy CIMT
The Association for Cancer Immunotherapy CIMT is a not-for-profit information and education platform that fosters the development and translation of cancer immunotherapies .
- “Scientific progress happens when scientists come together.” - Özlem Türeci/ At #CICON25 in Utrecht, we bring together the global cancer immunotherapy community . Register at www.cancerimmunotherapyconference.org
- June 12 (midnight CET) is the abstract submission deadline for #CICON25. www.cancerimmunotherapyconference.org
- Submit your abstract to #CICON25 in #Utrecht and present your research as poster or short talk: cancerimmunotherapyconference.org
- Can metastatic cancer be outsmarted by using the body’s innate immune system? At #CIMT2025, @maria-sibilia.bsky.social will present translational insights from mechanisms to therapeutics—exploring how the innate immune system can be harnessed to fight metastatic disease. www.meeting.cimt.eu
- Your front-row seat to the latest in cancer immunotherapy: www.cancerimmunotherapyconference.org Sept 10-12 in Utrecht @cancerresearchinst.bsky.social @enci-network.bsky.social
- The Swedish cancer immunologist and researcher Rolf Kiessling @ki.se is the recipient of the 2025 CIMT Lifetime Achievement Award for his discovery of natural killer (NK) cells. Don't miss his lecture on his pioneering discoveries, May 13, 18:00 at the CIMT Annual Meeting www.meeting.cimt.eu
- At #CIMT2025, Dario Neri @Philogen @ethzurich.bsky.social will take us on a journey through the past, present, and future of anti-cancer antibody-cytokine fusions—a field that holds immense promise for cancer therapy. Register now: ww.meeting.cimt.eu/registration
- Reposted by Association for Cancer Immunotherapy CIMTDon't miss PICI Investigator Hideho Okada, MD, PhD (@ucsfhealth) present novel T-cell immunotherapy strategies for resistant gliomas at #CIMT2025. Can i-o crack glioblastoma's notorious defense systems? Find out May 12-14 at Europe's Cancer Immunotherapy Meeting. Register: www.meeting.cimt.eu
- Glioblastomas are notoriously resistant—can T-cell therapies change the game? At #CIMT2025, Dr. Hideho Okada (UC San Francisco, and Parker Institute for Cancer Immunotherapy) will present T-cell-based immunotherapy strategies for malignant gliomas. Register at www.meeting.cimt.eu.
- What makes the immune microenvironment in lung cancer a key determinant of patient survival? Dr. Karina Silina, group leader at the Institute of Pharmaceutical Sciences @ethzurich.bsky.social will explain at #CIMT2025. Register now to join the conversation! www.meeting.cimt.eu/registration
- The 22nd CIMT Annual Meeting will present Nikolaos Sgourakis from @upenn.bsky.social & Children's Hospital of Philadelphia: “Revealing, Decoding and Targeting the Endogenous Cancer Antigen Repertoire". Register to attend Europe's Cancer Immunotherapy Meeting at www.meeting.cimt.eu
- At #CIMT2025, Dr. Barbara Maier (CeMM Research Center for Molecular Medicine in Vienna) will present her latest research on tumor-draining lymph nodes as a target for cancer immunotherapy. Register now: www.meeting.cimt.eu - Abstract submission deadline: March 7 #cancerimmunotherapy
- Reposted by Association for Cancer Immunotherapy CIMTInterested in investigating the principles that regulate the establishment of tumour environments that promote or inhibit the anti-tumour function of the immune system? Our group is currently recruiting a postdoctoral fellow. Learn more about our research 👇 www.cruk.manchester.ac.uk/research-gro...
- Reposted by Association for Cancer Immunotherapy CIMT[Not loaded yet]
- Glioblastomas are notoriously resistant—can T-cell therapies change the game? At #CIMT2025, Dr. Hideho Okada (UC San Francisco, and Parker Institute for Cancer Immunotherapy) will present T-cell-based immunotherapy strategies for malignant gliomas. Register at www.meeting.cimt.eu.
- Did you know chances are high that you will be selected to give a short talk at the 22nd CIMT Annual Meeting? 10% of all abstract submissions are chosen for an oral presentation at Europe's Cancer Immunotherapy Meeting. Learn more at www.meeting.cimt.eu/call-for-abstracts #cancerimmunotherapy
- Reposted by Association for Cancer Immunotherapy CIMT🧪 Looking for a state-of-the-art education in #cancer #research? ✏️ The applications to the International Cancer Doctoral Programme (ICDP) at the @champalimaudf.bsky.social are open until 11 March 2025. 👉 More info: fchampalimaud.org/education-ar... @itqbnova.bsky.social
